Article Text
PDF
Abstract
Objective Neonates requiring Non-InVasive respiratory Support (NIVS) are at high risk of device-related pressure injury (DRPI), with incidence rates of 20%–60% in extremely premature infants. Over a 4-year period, our team undertook a Quality Improvement Project to review aspects of the clinical management of NIVS: types of interfaces, introduction of hydrocolloid dressing and the development and implementation of nasal injury care plan (NICP) to reduce DRPI in high-risk neonates.
Design A prospective descriptive study was completed in three stages: trial of nCPAP interfaces, preintroduction NICP (2016–2018), post-NICP (2018–2020) and (2021–2022) to measure sustainability of implementation. Data included: gestational age (GA), birth weight, NIVS days, incidence, grade and day of DRPI. Statistical analysis of incidence rate ratio was completed between pre and postgroups.
Setting Australian neonatal intensive care unit.
Patients All neonates ≤32 weeks requiring nCPAP.
Interventions Evaluation of types of interfaces, introduction of hydrocolloid dressing and the development and implementation of NICP
Main outcome measures: incidence and severity of DRPI.
Results Total DRPI recorded in all CPAP babies pre/post NICP were (59/659 (9.0%), 26/574 (4.5%), p=0.0032, respectively). Analysis showed DRPI incidence rates per 1000 NIVS days ((10.6, 5.5), p=0.0001, respectively). 75 (88%) of DRPI occurred in the ≤32 week group of neonates requiring NIVS. Review of babies ≤32 weeks across the three intervals showed significant improvement with time (55 (19%); 27 (13%); 19 (9%), p=0.0001).
Conclusions Preferred nCPAP interface, nasal dressing and NICP have reduced the incidence and severity of DRPI in the NICU.
- Intensive Care Units, Neonatal
- Nursing Care
- Primary Health Care
Data availability statement
No data are available. Not applicable.
Statistics from Altmetric.com
Data availability statement
No data are available. Not applicable.
Footnotes
X @Aussiekidney
Contributors Contributors: MB, ALK and TC added to the design of the study, analysis, or interpretation of data. MB oversaw data collection. MB prepared the first draft of the paper; this and all subsequent drafts were reviewed and revised by all authors. All authors approved the final version submitted. Margaret Broom/MB acted as guarantor.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer-reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.